1.
Miettinen,
M.
& Lasota,
J.
Gastrointestinal stromal tumors--definition,
clinical,
histological,
immunohistochemical,
and molecular genetic features and differential diagnosis.
Virchows Arch. 438, 1–12 (2001).
2.
Kang,
H.
C.
et al. Beyond the GIST: Mesenchymal Tumors of the Stomach.
RadioGraphics 33, 1673–1690 (2013).
3.
Ma,
G.
L.,
Murphy,
J.
D.,
Martinez,
M.
E.
& Sicklick,
J.
K.
Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study.
Cancer Epidemiol.
Biomarkers Prev. 24, 298–302 (2015).
4.
Guidelines,
C.
P.
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up.
Ann.
Oncol. 25, iii21-iii26 (2014).
5.
Cai,
P.
Q.
et al. CT characterization of duodenal gastrointestinal stromal tumors.
Am.
J.
Roentgenol. 204, 988–993 (2015).
6.
Joensuu,
H.,
Hohenberger,
P.
& Corless,
C.
L.
Gastrointestinal stromal tumor.
Mod.
Soft Tissue Pathol.
Tumors Non-Neoplastic Cond. 382, 491–507 (2010).
7.
Fletcher,
C.
D.
M.
et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach.
Int.
J.
Surg.
Pathol. 10, 81–9 (2002).
8.
O’Regan,
K.
N.
et al. Gastrointestinal stromal tumors (GIST): Lesser known facts.
Clin.
Imaging 37, 821–829 (2013).
9.
Hong,
X.
et al. Gastrointestinal Stromal Tumor: Role of CT in Diagnosis and in Response Evaluation and Surveillance after Treatment with Imatinib.
RadioGraphics 26, 481–495 (2006).
10. Gastrointestinal Stromal Tumours.
American Joint Committee on Cancer (Springer,
2017).
11.
Nilsson,
B.
et al. Gastrointestinal stromal tumors: The incidence,
prevalence,
clinical course,
and prognostication in the preimatinib mesylate era - A population-based study in western Sweden.
Cancer 103, 821–829 (2005).
12.
Demetri,
G.
D.
et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
J.
Natl.
Compr.
Canc.
Netw. 5 Suppl 2,
S1–29; quiz S30 (2007).
13.
Benjamin,
R.
S.
et al. We should desist using RECIST,
at least in GIST.
J.
Clin.
Oncol. 25,
1760–4 (2007).